232 related articles for article (PubMed ID: 37251668)
1. Case report: Better late than never, but sooner is better: switch from CSII to sulfonylureas in two patients with neonatal diabetes due to KCNJ11 variants.
Mancioppi V; Pozzi E; Zanetta S; Missineo A; Savastio S; Barbetti F; Mellone S; Giordano M; Rabbone I
Front Endocrinol (Lausanne); 2023; 14():1143736. PubMed ID: 37251668
[TBL] [Abstract][Full Text] [Related]
2. Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of K
Ngoc CTB; Dien TM; De Franco E; Ellard S; Houghton JAL; Lan NN; Thao BP; Khanh NN; Flanagan SE; Craig ME; Dung VC
Front Endocrinol (Lausanne); 2021; 12():727083. PubMed ID: 34566892
[TBL] [Abstract][Full Text] [Related]
3. Molecular and clinical features of K
Hashimoto Y; Dateki S; Hirose M; Satomura K; Sawada H; Mizuno H; Sugihara S; Maruyama K; Urakami T; Sugawara H; Shirai K; Yorifuji T
Pediatr Diabetes; 2017 Nov; 18(7):532-539. PubMed ID: 27681997
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study.
Bowman P; Sulen Å; Barbetti F; Beltrand J; Svalastoga P; Codner E; Tessmann EH; Juliusson PB; Skrivarhaug T; Pearson ER; Flanagan SE; Babiker T; Thomas NJ; Shepherd MH; Ellard S; Klimes I; Szopa M; Polak M; Iafusco D; Hattersley AT; Njølstad PR;
Lancet Diabetes Endocrinol; 2018 Aug; 6(8):637-646. PubMed ID: 29880308
[TBL] [Abstract][Full Text] [Related]
5. Personalized precision medicine in extreme preterm infants with transient neonatal diabetes mellitus.
Kylat RI; Senguttuvan R; Bader MY
J Pediatr Endocrinol Metab; 2017 May; 30(5):593-596. PubMed ID: 28350539
[TBL] [Abstract][Full Text] [Related]
6. Transient neonatal diabetes with two novel mutations in the KCNJ11 gene and response to sulfonylurea treatment in a preterm infant.
Siklar Z; Ellard S; Okulu E; Berberoğlu M; Young E; Savaş Erdeve S; Mungan IA; Hacihamdioğlu B; Erdeve O; Arsan S; Oçal G
J Pediatr Endocrinol Metab; 2011; 24(11-12):1077-80. PubMed ID: 22308870
[TBL] [Abstract][Full Text] [Related]
7. Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China.
Li X; Xu A; Sheng H; Ting TH; Mao X; Huang X; Jiang M; Cheng J; Liu L
Pediatr Diabetes; 2018 Mar; 19(2):251-258. PubMed ID: 28791793
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers.
Stanik J; Gasperikova D; Paskova M; Barak L; Javorkova J; Jancova E; Ciljakova M; Hlava P; Michalek J; Flanagan SE; Pearson E; Hattersley AT; Ellard S; Klimes I
J Clin Endocrinol Metab; 2007 Apr; 92(4):1276-82. PubMed ID: 17213273
[TBL] [Abstract][Full Text] [Related]
9. Permanent neonatal diabetes by a new mutation in KCNJ11: unsuccessful switch to sulfonylurea.
Lau E; Correia C; Freitas P; Nogueira C; Costa M; Saavedra A; Costa C; Carvalho D; Fontoura M
Arch Endocrinol Metab; 2015 Dec; 59(6):559-61. PubMed ID: 26331221
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea.
Taberner P; Flanagan SE; Mackay DJ; Ellard S; Taverna MJ; Ferraro M
Diabetes Res Clin Pract; 2016 Jul; 117():104-10. PubMed ID: 27329029
[TBL] [Abstract][Full Text] [Related]
11. Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes.
Babiker T; Vedovato N; Patel K; Thomas N; Finn R; Männikkö R; Chakera AJ; Flanagan SE; Shepherd MH; Ellard S; Ashcroft FM; Hattersley AT
Diabetologia; 2016 Jun; 59(6):1162-6. PubMed ID: 27033559
[TBL] [Abstract][Full Text] [Related]
12. Sulfonylurea in the treatment of neonatal diabetes mellitus children with heterogeneous genetic backgrounds.
Zhang M; Chen X; Shen S; Li T; Chen L; Hu M; Cao L; Cheng R; Zhao Z; Luo F
J Pediatr Endocrinol Metab; 2015 Jul; 28(7-8):877-84. PubMed ID: 25781672
[TBL] [Abstract][Full Text] [Related]
13. Neonatal diabetes mellitus: a disease linked to multiple mechanisms.
Polak M; Cavé H
Orphanet J Rare Dis; 2007 Mar; 2():12. PubMed ID: 17349054
[TBL] [Abstract][Full Text] [Related]
14. Personalized medicine switching from insulin to sulfonylurea in permanent neonatal diabetes mellitus dictated by a novel activating ABCC8 mutation.
Mak CM; Lee CY; Lam CW; Siu WK; Hung VC; Chan AY
Diagn Mol Pathol; 2012 Mar; 21(1):56-9. PubMed ID: 22306677
[TBL] [Abstract][Full Text] [Related]
15. KCNJ11 in-frame 15-bp deletion leading to glibenclamide- responsive neonatal diabetes mellitus in a Chinese child.
Yang W; Wei H; Sang Y
J Pediatr Endocrinol Metab; 2013; 26(5-6):591-4. PubMed ID: 23640936
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of young infants presenting neonatal diabetes mellitus with continuous subcutaneous insulin infusion before genetic diagnosis.
Rabbone I; Barbetti F; Marigliano M; Bonfanti R; Piccinno E; Ortolani F; Ignaccolo G; Maffeis C; Confetto S; Cerutti F; Zanfardino A; Iafusco D
Acta Diabetol; 2016 Aug; 53(4):559-65. PubMed ID: 26831749
[TBL] [Abstract][Full Text] [Related]
17. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations.
Pearson ER; Flechtner I; Njølstad PR; Malecki MT; Flanagan SE; Larkin B; Ashcroft FM; Klimes I; Codner E; Iotova V; Slingerland AS; Shield J; Robert JJ; Holst JJ; Clark PM; Ellard S; Søvik O; Polak M; Hattersley AT;
N Engl J Med; 2006 Aug; 355(5):467-77. PubMed ID: 16885550
[TBL] [Abstract][Full Text] [Related]
18. Early Postnatal Use of Glibenclamide in Permanent Neonatal Diabetes Secondary to Antenatally Diagnosed KJCN11 Mutation.
Walton-Betancourth S; Ashford J; Beardsall K; Gooding N; Gurnell EM; Hendriks E; Hysted H; Lee J; Thankamony A; Tseretopoulou X; Win M; Williams RM
Horm Res Paediatr; 2022; 95(5):476-483. PubMed ID: 35817008
[TBL] [Abstract][Full Text] [Related]
19. Sulfonylurea therapy in two Korean patients with insulin-treated neonatal diabetes due to heterozygous mutations of the KCNJ11 gene encoding Kir6.2.
Kim MS; Kim SY; Kim GH; Yoo HW; Lee DW; Lee DY
J Korean Med Sci; 2007 Aug; 22(4):616-20. PubMed ID: 17728498
[TBL] [Abstract][Full Text] [Related]
20. [Neonatal diabetes: a disease linked to multiple mechanisms].
Flechtner I; Vaxillaire M; Cavé H; Froguel P; Polak M
Arch Pediatr; 2007 Nov; 14(11):1356-65. PubMed ID: 17931842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
